Market Tracker

09/02 7:17am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.99
Data as of Aug 29
 +0.0112 / +1.14%
Today’s Change
0.65
Today|||52-Week Range
4.00
+7.03%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.98
Today’s open0.98
Day’s range-- - --
Volume510,583
Average volume (3 months)643,706
Market cap$60.1M
Dividend yield--
Data as of 08/29/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-37.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...0.000.00%
BCLIBrainstorm Cell Ther...+0.00+0.80%
CASICASI Pharmaceuticals...-0.04-2.25%
PBMDPrima BioMed Ltd-0.01-0.93%
Data as of 08/29/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts